Skip to main content

HTRF Human Total Phospholamban Detection Kit, 500 Assay Points

The Total-Phospholamban kit can be used as a normalization assay for the phospho-Phospholamban kit.

Feature Specification
Application Cell Signaling
Sample Volume 16 µL

The Total-Phospholamban kit can be used as a normalization assay for the phospho-Phospholamban kit.

Product Variants
Unit Size: 500 Assay Points
Part #:
63ADK075PEG
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Request More Information

Overview

Total Phospholamban (PLN) cellular assay kit serves as a normalization assay with our Phospho-PLN kits, it is designed for the quantitative detection of total PLN, phosphorylated and unphosphorylated. The buffers of the HTRF phospho- and total PLN assays are compatible, enabling an analysis of the phosphorylated and the total protein populations from one lysate sample.

Specifications

Application
Cell Signaling
Brand
HTRF
Detection Modality
HTRF
Lysis Buffer Compatibility
Lysis Buffer 1
Lysis Buffer 3
Lysis Buffer 4
Lysis Buffer 5
Molecular Modification
Total
Product Group
Kit
Sample Volume
16 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Phosphoproteins
Target Species
Human
Technology
TR-FRET
Therapeutic Area
Cardiovascular
Unit Size
500 Assay Points

Video gallery

How it works

Total-phospholamban assay principle

The Total-Phospholamban assay quantifies the expression level of Phospholamban in a cell lysate. Contrary to Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis or transfer. The Total-Phospholamban assay uses two labeled antibodies: one coupled to a donor fluorophore, the other to an acceptor. Both antibodies are highly specific for a distinct epitope on the protein. In presence of Phospholamban in a cell extract, the addition of these conjugates brings the donor fluorophore into close proximity with the acceptor and thereby generates a FRET signal. Its intensity is directly proportional to the concentration of the protein present in the sample, and provides a means of assessing the proteins expression under a no-wash assay format.

1phospho-how-it-works-total-btk-assay-principle.svg

 

Total-phospholamban 2-plate assay protocol

The 2 plate protocol involves culturing cells in a 96-well plate before lysis then transferring lysates to a 384-well low volume detection plate before adding Total-Phospholamban HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.

2biomarkers-how-it-works-assay-protocol-alpha-tubulin-63adk072peg-63adk072peh.svg

 

Total-Phospholamban 1-plate assay protocol

Detection of total Phospholamban with HTRF reagents can be performed in a single plate used for culturing, stimulation and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.

2phospho-how-it-works-total-btk-1-plate-assay-protocol.svg

 

Assay validation

Total phospholamban assay on heart homogenate

Spontaneously hypertensive (SHR) heart and normal heart samples were homogenized using Revvity lysis buffer and supernatant was collected after centrifugation. 16 µL of lysate were transferred into a 384-well sv white microplate and 4 µL of the HTRF total Phospholamban detection reagents were added. The HTRF signal was recorded after an overnight incubation at room temperature.

1assay-validation-phospholamban-total-1.svg

 

HTRF Total phospholamban assay compared to western blotnd HTRF

Spontaneously hypertensive (SHR) heart from rats were homogenized using Revvity lysis buffer and supernatant was collected after 10-minute centrifugation. An HTRF Total-PLN assay was performed following the package insert instructions and equal amounts of sample were used in a side by side comparison with WB.

The HTRF total-PLN assay showed an improved sensitivity compared to WB and was able to detect PLN at 1.5µg/mL whereas the WB detection threshold was 13 µg/mL.

2assay-validation-pln-total-1.svg

 

Simplified pathway

Simplified pathway for PLN

Phospholamban (PLN) plays a crucial role in heart failure through its control of cardiac sarcoplasmic reticulum (SR) Ca2+-ATPase (SERCA2a). This protein has a Ca2+ pump included in the SR membrane, and once activated, Ca2+ goes inside SR. Insufficient SERCA2a activity is a hallmark of heart failure. Dephosphorylated PLN inhibits SERCA2a, whereas phosphorylation of PLN at either the Ser16 site by PKA or the Thr17 site by CaMKII reverses the inhibition of SERCA2a. The PLN phosphorylation state regulates the activity of this Ca2+ pump. Relaxation is driven by dephosphorylation of PLN, and contraction  by the phosphorylation status.

This small protein, is present in cardiac, smooth, and slow-twitch skeletal muscles. However, its regulatory effects have mainly been studied in cardiac muscle. The activation process is not well known, but 2 main pathways are described ending in 2 different phosphaorylations: on residue Serine 16, or on Threonine 17. Binding of a β-agonist to its receptor activates G protein, which enhances adenylate cyclase (AC) activity. AC catalyzes cAMP formation, which activates PKA. PKA phosphorylates the L-type Ca2+ channel, increasing the Ca2+ influx, and phosphorylates PP1  and the Ser16 residue of PLN. An increase in intracellular Ca2+ causes the activation of CaMKII. This autophosphorylation state is also controlled by PP1. CaMKII in turn phosphorylates PLN at the Thr17 residue.

2phospho-pathway-phospholamban-phospho-t17-kit-63adk074peg-63adk074peh-63adk074pey.svg

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Scroll Icon